Advertisement
Screener

CYTOSORBENTS CORPORATION (CTSO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

2.3 / 5 stars · 44/97 Roast Me

CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

CYTOSORBENTS CORPORATION (CTSO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 929.12 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06

  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 653.97K shares, a 329.12% increase year-over-year.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 275.15K shares, a 691.09% increase year-over-year.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 152.40K shares, a 19.31% increase year-over-year.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 34.78K shares, a 91.68% decline year-over-year.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 373.77K shares, a 53.11% decline from fiscal 2024.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 797.21K shares, a 70.59% increase from fiscal 2023.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 467.33K shares, a 105.69% increase from fiscal 2022.
  • CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 227.20K shares, a 944.33% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed
2026-06-30653.97K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
929.12K shares
10-Q · filed 2026-08-06
2026-03-31275.15K shares
10-Q · filed 2026-05-13
2025-12-31373.77K shares
10-K · filed 2026-03-30
2025-06-30152.40K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
187.18K shares
10-Q · filed 2025-08-07
277.78K shares
derived: sum of 3 quarters · filed 2026-03-30
438.85K shares
derived: sum of 4 quarters · filed 2026-03-30
2025-03-3134.78K shares
10-Q · filed 2025-05-14
125.38K shares
derived: sum of 2 quarters · filed 2026-03-30
286.45K shares
derived: sum of 3 quarters · filed 2026-03-30
414.19K shares
derived: sum of 4 quarters · filed 2026-03-30
2024-12-3190.60K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
251.67K shares
derived: sum of 2 quarters · filed 2026-03-30
379.41K shares
derived: sum of 3 quarters · filed 2026-03-30
797.21K shares
10-K · filed 2026-03-30
2024-09-30161.07K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
288.81K shares
derived: sum of 2 quarters · filed 2024-11-07
706.61K shares
10-Q · filed 2024-11-07
738.16K shares
derived: sum of 4 quarters · filed 2025-03-31
2024-06-30127.73K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
545.54K shares
10-Q · filed 2024-08-13
577.09K shares
derived: sum of 3 quarters · filed 2025-03-31
680.46K shares
derived: sum of 4 quarters · filed 2025-03-31
2024-03-31417.80K shares
10-Q · filed 2024-05-09
449.35K shares
derived: sum of 2 quarters · filed 2025-03-31
552.73K shares
derived: sum of 3 quarters · filed 2025-03-31
698.82K shares
derived: sum of 4 quarters · filed 2025-03-31
2023-12-3131.55K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
134.93K shares
derived: sum of 2 quarters · filed 2025-03-31
281.02K shares
derived: sum of 3 quarters · filed 2025-03-31
467.33K shares
10-K · filed 2025-03-31
2023-09-30103.38K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
249.47K shares
derived: sum of 2 quarters · filed 2023-11-09
435.78K shares
10-Q · filed 2023-11-09
500.32K shares
derived: sum of 4 quarters · filed 2024-03-15
2023-06-30146.10K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
332.40K shares
10-Q · filed 2023-08-01
396.94K shares
derived: sum of 3 quarters · filed 2024-03-15
468.21K shares
derived: sum of 4 quarters · filed 2024-03-15
2023-03-31186.31K shares
10-Q · filed 2023-05-02
250.84K shares
derived: sum of 2 quarters · filed 2024-03-15
322.12K shares
derived: sum of 3 quarters · filed 2024-03-15
378.39K shares
derived: sum of 4 quarters · filed 2024-03-15
2022-12-3164.54K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
135.81K shares
derived: sum of 2 quarters · filed 2024-03-15
192.08K shares
derived: sum of 3 quarters · filed 2024-03-15
227.20K shares
10-K · filed 2024-03-15
2022-09-3071.27K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
127.54K shares
derived: sum of 2 quarters · filed 2022-11-03
162.67K shares
10-Q · filed 2022-11-03
169.85K shares
derived: sum of 4 quarters · filed 2024-03-15
2022-06-3056.27K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
91.40K shares
10-Q · filed 2022-08-02
98.58K shares
derived: sum of 3 quarters · filed 2024-03-15
103.58K shares
derived: sum of 4 quarters · filed 2024-03-15
2022-03-3135.12K shares
10-Q · filed 2022-05-03
42.31K shares
derived: sum of 2 quarters · filed 2024-03-15
47.31K shares
derived: sum of 3 quarters · filed 2024-03-15
2021-12-317.18K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
12.19K shares
derived: sum of 2 quarters · filed 2024-03-15
21.76K shares
10-K · filed 2024-03-15
2021-09-305.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
14.57K shares
10-Q · filed 2021-11-04
2021-06-309.57K shares
10-Q · filed 2021-08-03
2020-12-312.39K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
2.48K shares
derived: sum of 2 quarters · filed 2023-03-09
22.04K shares
derived: sum of 3 quarters · filed 2023-03-09
226.44K shares
10-K · filed 2023-03-09
2020-09-3087.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
19.64K shares
derived: sum of 2 quarters · filed 2020-11-04
224.05K shares
10-Q · filed 2020-11-04
236.37K shares
derived: sum of 4 quarters · filed 2022-03-10
2020-06-3019.55K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
223.96K shares
10-Q · filed 2020-08-04
236.28K shares
derived: sum of 3 quarters · filed 2022-03-10
236.28K shares
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31204.41K shares
10-Q · filed 2020-05-05
216.72K shares
derived: sum of 2 quarters · filed 2022-03-10
216.72K shares
derived: sum of 3 quarters · filed 2022-03-10
216.72K shares
derived: sum of 4 quarters · filed 2022-03-10
2019-12-3112.32K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
12.32K shares
derived: sum of 2 quarters · filed 2022-03-10
12.32K shares
derived: sum of 3 quarters · filed 2022-03-10
16.32K shares
10-K · filed 2022-03-10
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
0.00 shares
derived: sum of 2 quarters · filed 2019-11-05
4.00K shares
10-Q · filed 2019-11-05
4.00K shares
derived: sum of 4 quarters · filed 2021-03-09
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
4.00K shares
10-Q · filed 2019-08-06
4.00K shares
derived: sum of 3 quarters · filed 2021-03-09
4.00K shares
derived: sum of 4 quarters · filed 2021-03-09
2019-03-314.00K shares
10-Q · filed 2019-05-07
4.00K shares
derived: sum of 2 quarters · filed 2021-03-09
4.00K shares
derived: sum of 3 quarters · filed 2021-03-09
4.80K shares
derived: sum of 4 quarters · filed 2021-03-09
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
0.00 shares
derived: sum of 2 quarters · filed 2021-03-09
800.00 shares
derived: sum of 3 quarters · filed 2021-03-09
800.00 shares
10-K · filed 2021-03-09
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
800.00 shares
derived: sum of 2 quarters · filed 2018-11-06
800.00 shares
10-Q · filed 2018-11-06
2.70K shares
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30800.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
800.00 shares
10-Q · filed 2018-08-02
2.70K shares
derived: sum of 3 quarters · filed 2020-03-05
2.70K shares
derived: sum of 4 quarters · filed 2020-03-05
2018-03-310.00 shares
10-Q · filed 2018-05-08
1.90K shares
derived: sum of 2 quarters · filed 2020-03-05
1.90K shares
derived: sum of 3 quarters · filed 2020-03-05
1.90K shares
derived: sum of 4 quarters · filed 2020-03-05
2017-12-311.90K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
1.90K shares
derived: sum of 2 quarters · filed 2020-03-05
1.90K shares
derived: sum of 3 quarters · filed 2020-03-05
34.02K shares
10-K · filed 2020-03-05
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
0.00 shares
derived: sum of 2 quarters · filed 2017-11-09
32.12K shares
10-Q · filed 2017-11-09
39.71K shares
derived: sum of 4 quarters · filed 2019-03-07
2017-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
32.12K shares
10-Q · filed 2017-08-07
39.71K shares
derived: sum of 3 quarters · filed 2019-03-07
53.80K shares
derived: sum of 4 quarters · filed 2019-03-07
2017-03-3132.12K shares
10-Q · filed 2017-05-08
39.71K shares
derived: sum of 2 quarters · filed 2019-03-07
53.80K shares
derived: sum of 3 quarters · filed 2019-03-07
57.07K shares
derived: sum of 4 quarters · filed 2019-03-07
2016-12-317.59K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
21.68K shares
derived: sum of 2 quarters · filed 2019-03-07
24.95K shares
derived: sum of 3 quarters · filed 2019-03-07
27.35K shares
10-K · filed 2019-03-07
2016-09-3014.08K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
17.36K shares
derived: sum of 2 quarters · filed 2016-11-07
19.76K shares
10-Q · filed 2016-11-07
2016-06-303.27K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
5.67K shares
10-Q · filed 2016-08-09
2016-03-312.40K shares
10-Q · filed 2016-05-09
2015-12-310.00 shares
10-K · filed 2018-03-08
2014-12-31-49.31K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
-49.31K shares
derived: sum of 2 quarters · filed 2017-03-03
2.50K shares
10-K · filed 2017-03-03
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
51.81K shares
10-Q · filed 2014-11-12
2014-06-3051.81K shares
10-Q · filed 2014-08-12
2013-12-31-8.27K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
-8.27K shares
derived: sum of 2 quarters · filed 2015-03-31
1.13K shares
10-K · filed 2015-03-31
28.24K shares
10-K · filed 2014-03-31
2013-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
9.40K shares
10-Q · filed 2013-11-06
2013-06-309.40K shares
10-Q · filed 2013-08-14
2012-12-31190.78K shares
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25